Max Parker Britain Max Parker Britain

WATCH: Soap actors who play on-screen brothers get engaged in real life

Reading now: 874
www.queerty.com

A post shared by Max Parker (@maxparker____) British actors Max Parker and Kris Mochrie are engaged to marry after a beach proposal over the weekend.The actors play brothers Luke and Lee Posner on the hit British soap Emmerdale.

The Sun leaked the news the two men were dating in summer 2020 after they began posting photos of themselves on holiday together on Instagram.The rumors were confirmed in September that year when Mochrie gave an interview to The Mirror.

In December 2020, Parker talked to Attitude about his sexuality and relationship with Mochrie, revealing they had moved in together.Related: Actor Max Parker confirms he’s gay and living with fellow soap starOver the weekend, Parker and Mochrie both revealed on Instagram they’d got engaged.

It appears Parker popped the question on Saturday during a trip to the beach.Parker posted a couple of photos, along with a video of the actual proposal: “He deserves the world, but the best I could do was promise him my heart.

Read more on queerty.com
The website meaws.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

19.02 / 15:55
hiv Treating HIV is about to get a whole lot easier
Related: FDA approves first long-acting HIV medication: a monthly injectionThe once-every-two-month injection is for HIV-positive adults who are already virally suppressed, have shown no previous treatment failure or resistance to either of the drugs involved.The FDA granted approval after results from a trial showed the injections remained efficient if given every couple of months.The lead researcher involved with that trial, Turner Overton, MD, a professor of medicine in the division of infectious diseases at the University of Alabama at Birmingham, said in a statement, “Many people living with HIV face challenges with daily therapies and are interested in alternative dosing options.“In clinical trials, approximately nine out of every 10 trial participants preferred long-acting cabotegravir and rilpivirine dosed every two months compared to daily oral cabotegravir and rilpivirine.”Viiv Healthcare is predominantly owned by GlaxoSmithKline. Lynn Baxter, Head of North America at ViiV Healthcare, said in a statement announcing the approval, “Today’s approval is a remarkable achievement given where HIV treatment was just a decade ago.
DMCA